55403-35-5

Basic information

• Product Name: 3-Amino-6-(4-methylpiperazin-1-yl)pyridine
• Synonyms: 3-Amino-6-(4-methylpiperazin-1-yl)pyridine;3-Amino-6-(4-methylpiperazin-1-yl)pyridine Hydrochloride;6-(4-Methyl-piperazin-1-yl)pyridin-3-ylamine;6-(4-methyl-1-piperazinyl)-3-pyridinamine(SALTDATA: FREE);5-Amino-2-(4-methylpiperazin-1-yl)pyridine;6-(4-Methylpiperazin-1-yl)pyridin-3-amine, 1-(5-Amniopyridin-2-yl)-4-methylpiperazine;6-(4-Methyl-1-piperazinyl)-3-pyridinaMine 4HCl
• CAS NO: 55403-35-5
• Molecular Formula: C₁₀H₁₆N₄
• Molecular Weight: 192.27
• EINECS: 200-258-5
• Product Categories: Amines and Anilines;Heterocycles;pharmacetical
• Mol File: 55403-35-5.mol
• Article Data: 20

Chemical Properties

• Melting Point: 106-108°
• Boiling Point: 388.7 °C at 760 mmHg
• Flash Point: 188.9 °C
• Appearance: /
• Density: 1.142 g/cm³
• Vapor Pressure: 3E-06mmHg at 25°C
• Refractive Index: 1.593
• Storage Temp.: Keep in dark place,Sealed in dry,Store in freezer, under -20°C
• PKA: 9.35±0.29(Predicted)
• CAS DataBase Reference: 3-Amino-6-(4-methylpiperazin-1-yl)pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Amino-6-(4-methylpiperazin-1-yl)pyridine(55403-35-5)
• EPA Substance Registry System: 3-Amino-6-(4-methylpiperazin-1-yl)pyridine(55403-35-5)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 55403-35-5(Hazardous Substances Data)

Usage

General Description

3-Amino-6-(4-methylpiperazin-1-yl)pyridine is a chemical compound with the molecular formula C11H16N4. It is a heterocyclic organic compound that contains both a pyridine and a piperazine ring. The compound is used in pharmaceutical research as a building block for the synthesis of potential drug candidates. It is also known for its potential therapeutic effects on various diseases, including cancer, and has been the subject of several research studies. Additionally, it has been identified as a potential target for drug development due to its unique structure and potential biological activities. Overall, 3-Amino-6-(4-methylpiperazin-1-yl)pyridine is a versatile compound with potential applications in medicinal chemistry and drug development.

InChI:InChI=1/C10H16N4/c1-13-4-6-14(7-5-13)10-3-2-9(11)8-12-10/h2-3,8H,4-7,11H2,1H3

Upstream product

• 4548-45-2 2-chloro-5-nitropyridine 
• 109-01-3 1-methyl-piperazine 
• 24903-85-3 2-isopropoxy-5-nitropyridine 
• 4487-59-6 2-bromo-5-nitropyridine 
• 55403-34-4 1-methyl-4-(5-nitropyridin-2-yl)piperazine 

Downstream Products

• 936929-87-2 2-[2-hydroxy-5-(2-methoxy-pyridin-3-yl)-phenyl]-1H-benzoimidazole-5-carboxylic acid [6-(4-methyl-piperazin-1-yl)-pyridin-3-yl]-amide 
• 1388831-95-5 N-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-2-(6-phenylimidazo[2,1-b]thiazol-3-yl)acetamide 
• 1388831-97-7 2-(6-(4-chlorophenyl)imidazo[2,1-b]thiazol-3-yl)-N-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-acetamide 
• 1429297-29-9 C₂₅H₂₆Cl₂FN₅O₃ 
• 943745-30-0 (4Z)-6-bromo-4-({[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino}methylene)isoquinoline-1,3(2H,4H)-dione 
• 1050499-93-8 2-(3-(2-(6-(4-Methylpiperazin-1-yl)pyridin-3-ylamino)pyrimidin-4-ylamino)phenyl)acetonitrile 
• 1050499-94-9 N₄-(3-chloro-4-fluorophenyl)-N₂-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)pyrimidine-2,4-diamine 
• 290297-26-6 netupitant 
• 290297-23-3 2,2-dimethyl-N-[6-(4-methyl-piperazin-1-yl)-4-o-tolyl-pyridin-3-yl]-propionamide 
• 290297-25-5 methyl-[6-(4-methyl-piperazin-1-yl)-4-o-tolyl-pyridin-3-yl]-amine 

Relevant articles and documents

Discovery of novel TrkA allosteric inhibitors: Structure-based virtual screening, biological evaluation and preliminary SAR studies

Tropomyosin receptor kinases A (TrkA) is a potential therapeutic target for the treatment of numerous tumor types and chronic pain. However, most of the reported TrkA inhibitors are ATP competitive pan-Trks inhibitors that lack subtype selectivity. A sele

WEE1 inhibitors as well as preparation and application thereof

The invention relates to WEE1 inhibitors as well as preparation and application thereof. The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, solvates, polymorphs or isomers thereof, and their use in the preparation of medicaments for the treatment of diseases associated with WEE1 activity.

HISTONE METHYLTRANSFERASE EZH2 INHIBITOR, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF

The invention relates to a histone methyltransferase EZH2 inhibitor, a preparation method and pharmaceutical use thereof. In particular, the invention relates to a compound represented by the general formula (I), a preparation method thereof, a pharmaceut